SHANDONG XINHUA PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 719 for the last quarter is 2.16 B HKD, and it's 10.56% lower compared to the previous quarter. The net income of Q3 24 is 85.61 M HKD.